Get App

Co-Partners

Associate Partners

you are here: HomeNewsBusiness
Last Updated : Apr 25, 2019 04:56 PM IST | Source: PTI

Dr Reddy's gets approval for anti-platelet drug in China

Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Dr Reddy's Laboratories on April 25 said it has received approval for anti-platelet drug Clopidogrel in China. "The company believes that the sales from this product will not be material in the current financial year, that is 2019-20," Dr Reddy's Laboratories said in a regulatory filing.

Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots.

Shares of Dr Reddy's Laboratories Thursday closed at Rs 2,930 per scrip on the BSE, up 2.61 per cent from its previous close.
First Published on Apr 25, 2019 04:53 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant